Research - News
Prostate cancer physicians look to provide personalized medicine to prostate cancer patients with a new medical device.
UAB is the first hospital in Alabama to implant a new electrical stimulator to combat sleep apnea and snoring.
Blacks are four times more likely than their white counterparts to die from stroke at age 45.
UAB has received a grant to develop and implement Ebola and infectious disease training to further protect health care and public safety workers.
Among black men, those with a high degree of West African genetic ancestry have less abdominal fat than those with a lower degree.
UAB is part of a national study aimed at teaching medical students the best ways to help their future patients maintain a healthy weight.
AIMTech’s ResistX treadmill will make its debut at the American College of Sports Medicine’s annual conference.
UAB researcher Sarah Parcak, Ph.D., has already shown the world how to find ancient sites from space. Now her graduate student is using remote sensing data to find a different kind of hidden treasure: uranium.
Cystic fibrosis lung cells were restored to 50 percent of healthy function in work that provides the first evidence that novel therapeutic strategies for human patients can be identified based on yeast studies.
UAB engineering professor Dean Sicking’s SAFER Barriers will be installed at the historic Le Mans Race Circuit.
Big data provides insight into patient readmission after pediatric neurosurgery.
Researchers from UAB, Emory and Microsoft demonstrate that HIV has evolved to be pre-adapted to the immune response, worsening clinical outcomes in newly infected patients.
UAB researchers will use a $1.8 million grant to look at single cells for altered expression of the interferon gamma receptor gene.
VA Research support for UAB clinicians and scientists has been important for six decades.
Longtime VP for Research and Economic Development Richard B. Marchase, Ph.D., plans to retire at the end of 2016. During his tenure, UAB annual research expenditures grew from $331 million to $510 million.
A treatment used for depression, Parkinson’s disease and autism shows promise to alleviate obesity in binge-eating disorder patients.
Results show that JAK/STAT pathway inhibitors may be a new class of therapeutic treatments for patients with Parkinson’s disease. Acting by reducing inflammation, they prevent neurodegeneration in animal models and may be an important new approach to slow progression of the disease.
Cutting-edge technology and research brings national attention to UAB.
Understanding how people respond to aspirin is key in terms of knowing who will benefit from it.
The facility will enable new distracted-driving research, addressing a major public health issue that is a leading cause of highway and traffic-related injuries and death.
The UAB Division of Rheumatology and Immunology and the Division of Cardiovascular Disease look at effects of Allopurinol in healthy adults age 18-40.
Researchers have proposed a model that resolves a seeming paradox in one of the most intriguing areas of the brain, exploring how immature granule cells in the dentate gyrus appear able to enhance pattern separation due to lesser synaptic connectivity than mature cells.
UAB professor leads study in Brazil to help further understand the effects of Zika virus during pregnancy.
Customized deep-coverage, next-generation sequencing will replace the current state-of-the-art approach.
UAB’s new REACT Center is the national coordinating center for six centers designed to promote research and train scientists and clinicians in the medical rehabilitation field.
UAB researchers uncover new information about drivers’ likelihood to participate in risky roadway behavior.
An international clinical trial for a new HIV antibody, VRC01 begins in late spring at UAB as part of the Antibody Mediated Prevention study.
A resuscitation study found another small step to help improve out-of-hospital cardiac arrest survival.
Research funding awarded to evaluate the effectiveness of disease-specific outcomes of patients using biologic therapies.
The innate immune systems of plants and plant pathogens are in a biological arms race, and if plants lose, food sources may diminish. Mukhtar probes the genetics and molecular mechanisms of plant immunity.